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Summary 
Latent and activated forms of Stat1 and Stat6 have 
beenexpressed and purified, enabling biochemical ex- 
periments relating to their functional activities. Stat1 
bound to a phosphotyrosine peptide derived from the 
IFNr receptor with a KD of 60 nY, whereas Stat6 bound 
to an IL-4 receptor peptide with a KD of 300 nM. Stat- 
receptor peptlde interactions were specific and depen- 
dent upon tyrosine phosphorylation. Activated forms 
of Stat1 and Stat6 were used to select their optimal 
DNA binding sites. Stat1 selected a recognltlon site 
having dyad half-sites separated by 3 bp. Stat6 se- 
lected a recognition site composed of the same dyad 
half-sites, yet separated by 4 bp. Chimeric Stat1 -Stat6 
recombinants were expressed, purlfled, and assayed 
for receptor coupling and DNA binding specificity. 
Such studies led to the identification of polypeptide 
domains that specify these activities. These observa- 
tions provide a framework for understanding how dlf- 
ferent cytokines elicit distinctive patterns of gene ex- 
pression. 
Introduction 
Cytokines coordinate biological response by reprogram- 
ming gene expression in cells bearing their cognate recep 
tors. Cells often display receptors for more than one cyto- 
kine, yet respond selectively upon stimulation by different 
hormonal ligands. This phenomenon is evident during the 
formation of the hematopoietic and lymphocytic lineages 
of vertebrates. For example, bipotential CD4+ T-helper 
lymphocytes can be stimulated to either self-renew or 
progress along one of two terminal differentiation path- 
ways in response to various cytokines (Sad and Mosmann, 
1994). The fact that different cytokines can elicit different 
biological effects in the same cell leads to the prediction 
that cytokine-receptor interactions catalyze signaling 
events sufficiently distinct to reprogram gene expression 
selectively. 
The biological effects of cytokines are transmitted by 
membrane-bound receptors. A key event resulting from 
ligand binding is receptor oligomerization, often entailing 
the formation of heteromeric complexes (Heldin, 1995). 
The intracellular domains of members of the hematopoi- 
etic cytokine receptor superfamily do not specify intrinsic 
catalytic activity (Kishimoto et al., 1994). Following ligand- 
mediated oligomerization, these receptors activate tyro- 
sine kinases belonging to the Janus kinase (Jak) family. 
In turn, Jak kinases catalyze phosphorylation of a class 
of transcription factors termed signal transducers and acti- 
vators of transcription (Stat proteins). Stat phosphotylation 
results in the formation of dimeric transcription factors that 
rapidly translocate from cytoplasm to nucleus (Darnell et 
al., 1994). 
Stat proteins represent prime candidates for mediating 
the genetic reprogramming activity elicited by cytokines. 
Six distinct Stat proteins have now been characterized 
(Briscoe et al., 1994; I hle and Kerr, 1995). Extensive stud- 
ies have given evidence that different Stat proteins are 
activated in response to different polypeptide ligands. The 
observed selectivity of Stat activation could result from 
restricted expression patterns of cytokine receptors or Stat 
proteins. If a cell does not contain functional receptors for 
a particular cytokine, or lacks an integral Stat protein, it 
should be immune to the biological effects of that cytokine. 
Restricted expression cannot, however, account entirely 
for the selectivity of Stat activation and biological re- 
sponse. For example, THpl cells, a transformed line of 
human monocytes, activate Stat1 in response to inter- 
feronr (IFNy). When these same cells are treated with 
interleukin-4 (IL+, a different Stat protein is activated. 
The IL&induced Stat protein, initially designated IL-4 Stat 
and hereafter termed Stat6, is related in primary amino 
acid sequence to Statl, yet encoded by a different gene 
(Hou et al., 1994). Thus, in the case of a pure population 
of human monocytes, different cytokines activate different 
Stat proteins. 
Clues relevant to the selectivity of Stat activation 
emerged initially from studies using peptides derived from 
the IFNy and IL-4 receptors. Greenlund et al. (1994) found 
that a synthetic tyrosine phosphopeptide derived from the 
IFNy receptor was capable of blocking Stat1 activation 
when added to permeabilized HeLa cells. Moreover, a bio- 
tinylated derivative of this same peptide was shown to 
be capable of immobilizing Stat1 on avidincoated beads. 
Given prior evidence that the relevant tyrosine residue of 
the IFNy receptor is critical for interferon signaling, 
Greenlund and colleagues (1994) hypothesized that Stat1 
might couple directly to the IFNy receptor at some point 
during its activation cycle. 
Similar interpretations have emerged from studies of 
Stat activation by IL-4 (Hou et al., 1994). In this case, it was 
shown that two tyrosine phosphopeptides derived from the 
IL-4 receptor (IL-4R) were capable of inhibiting the DNA 
binding activity of purified Stat6. Inhibition was found to 
result from the ability of IL4Rderived phosphopeptides 
to dissociate Stat6 dimers, leading to the prediction that 
the dimer interface of Stat8 might coincide with its receptor 
docking domain. 
If correct, the interpretations of the aformentioned stud- 
ies provide a conceptual framework for understanding how 
different cytokines are capable of selective Stat activation. 
IFNy activates Statl, yet not Stat6, because the former 
protein bears intrinsic affinity for a docking site within the 
intracellular domain of the IFNyR. Likewise, IL4 leads to 
selective Stat activation because of the affinity of Stat8 for 
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Figure 1. Characterization of Latent and Active Forms of Stat1 and 
Stat6 
Saculovirus recombinants expressing Stat1 and Stat6 were used to 
infect insect cells in the absence or presence of a recombinant virus 
encoding Jalc? (see Experimental Procedures). Latent (L) and acti- 
vated (A) proteins were purified to homogeneity and sized on denatur- 
ing SDS polyac@amide gels that were either stained with Coomassie 
brilliant blue (top) or transferred onto nitrocellulose filters for Western 
blot characterization using antibodies to Stat6 (second panel), Stat1 
(third panel) and phosphotyrosine (bottom). 
two tyrosine-phosphorylated determinants located within 
the cytoplasmic domain of the IL-4R. 
Although conceptually appealing, each of the aformen- 
tioned studies failed to establish firmly a direct Stat-recep 
tor interaction. The ability of the IFNy receptor phospho- 
peptide to immobilize Stat1 was observed in experiments 
utilizing crude cytoplasmic proteins (Greenlund et al., 
1994). As such, the possible involvement of an unidentified 
adapter protein could not be ruled out. Evidence favoring 
direct docking between the IL-4R and Stat6 was also in- 
complete. Although the study was carried out using puri- 
fied Stat6, selective affinity of the IL-rlR-derived peptides 
for Stat6 was inferred from their inhibitory activity and not 
shown directly (Hou et al., 1994). Previous studies llkewise 
failed to resolve how different Stat proteins might, once 
activated, selectively reprogram gene expression. 
Here, we show that Stat1 and Stat6 bind directly and 
selectively to phosphopeptides derived from their actlvat- 
ing receptors. We likewise show that, once activated, 
these two proteins recognize different binding sites on 
DNA. Finally, we provide evidence that selective receptor 
coupling and differential DNA binding map to distinct func- 
tional domains within a Stat protein. 
Results 
To study the molecular specificities of different Stat pro- 
teins, we first purified both latent (nonphosphorylated) and 
active (tyrosine-phosphorylated) forms of Stat1 and Stat6. 
Latent proteins were purified from insect cells infected with 
recombinant baculovirus expression vectors. The active 
forms of Stat1 and Stat6 were purified from insect cells 
doubly infected with a Stat expression vector and a recom- 
binant baculovirus encoding Jak2 (see Experimental Pro- 
cedures). The recombinant proteins were tagged at their 
carboxyl termini with nine His residues to facilitate purifica- 
tion. Figure 1 provides molecular characterization of the 
latent and active forms of Stat1 and Stat6. Most notably, 
only the active forms of the two proteins reacted with anti- 
bodies to phosphotyrosine. 
A fluorescence polarization assay (Dandliker et al., 
1961) was utilized to measure the binding affinities of the 
latent formsof Stat1 and Stat6 tofluorescein-labeled phos- 
phopeptides derived from the IFNy and IL-4 receptors. 
When excited with plane-polarized light, the fluorescein 
attached to the small peptides initially emitted polarized 
light. Rapid depolarization occurred, however, owing to 
the free rotation of the small phosphopeptides. Upon bind- 
ing to their cognate Stat, the fluorescein-labeled phospho- 
peptides became attached to the much larger molecule. 
Rotation of the bound peptide slowed, thereby reducing 
the rate of depolarization of emitted light and leading to 
a high steady-state polarization. By measuring polariza- 
tion at various protein concentrations, it was possible to 
estimate Stat-phosphopeptide binding constants. Stat1 
bound to the IFNy receptor-derived phosphopeptide with 
an apparent K. of about 50 nM, whereas Stat6 bound to 
the IL-4R-derived phosphopeptide with an apparent KD of 
about 300 nM (estimated from the binding curves in Fig- 
ure 2). 
The binding selectivity of receptor phosphopeptides to 
Stat1 and Stat6 was examined by competition assays us- 
ing unlabeled peptides. As shown in Figure 3A, the tyro- 
sine-phosphorylated peptide derived from the IFNy recep- 
tor competed effectively with itself (fluorescein-labeled 
peptide) in binding of Statl, with a concentration of 50% 
inhibition at 0.6 PM. The desphosphate form of this same 
peptide failed to compete even when added at a 1 ,OO@fold 
higher concentration (Figure 36). Likewise, even when 
added in considerable molar excess, the IL-+R-derived 
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Figure 2. Saturation Binding Assays of Stat-Phosphopeptide Interac- 
tion by Fluorescence Polarization 
Assays measured in polarization (milli-polarization, mP) of fluorescent 
peptides (10 nM) as a function of added Stat protein. 
(A) Top shows binding of tyrosine-phosphorylated fluorescein (FL)- 
conjugated IFNy receptor peptide (FL)-GYPDKHVL to purified latent 
Statl. 
(B) Bottom shows binding of tyrosinephosphorylated fluorescein- 
conjugated lL-4R peptide (FL)-GYPKPFQDL to purified latent Stat3 
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phosphopeptide hardly competed for Stat1 binding to its 
putative IFNy receptor docking site (Figure 3C). The same 
pattern of binding selectivity was observed in fluorescence 
polarization assays of Stat6 interaction wfth the lL4R phos- 
phopeptide (Figures 3D, 3E, and 3F), with a concentration 
of 50% inhibition at 5 uM forthe unlabeled and phosphory- 
lated lL4R peptide. The data shown in Figure 2 and Figure 
3 provide evidence of direct and selective interaction be- 
tween latent Stat proteins and the intracellular domains 
of their cognate receptors, and thereby offer a rational 
explanation as to why IFNy selectively activates Statl, and 
IL4 selectively activates Stat6. 
Having established receptor coupling as the probable 
basis for selective cytokine-mediated Stat activation, we 
next turned to the question of whether different Stat pro- 
teins might display distinct DNA binding specificities, and 
thereby be capable of regulating unique programs of gene 
expression. To this end, purified activated Stat1 and Stat6 
were used in binding site selection assays to identify opti- 
mal DNA recognition elements (Blackwell and Weintraub, 
1990; Schindler et al., 1992). A radioactively labeled DNA 
fragment bearing a randomized 14 residue sequence, 
flanked by polymerase chain reaction (PM) priming sites, 
was synthesized and mixed independently with the acti- 
vated forms of Stat1 and Stat& Protein-bound DNA frag- 
ments were separated from unbound DNA by the electro- 
phoretic mobility shift assay (EMSA), recovered, and PCR 
amplified (see Experimental Procedures). Following three 
cycles of selection, the resulting DNA was cloned. Se- 
quence analysis of 45 DNA fragments selected by Stat1 
revealed a canonical recognition element bearing dyad 
symmetric half-sites of the sequence 5’-TX-3 separated 
bythree residues@‘-TTCN3GAA-3’). Cfthe cloned binding 
sites selected by Stat1 , 37 contained a perfect match to 
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Figure 3. Competition Binding AssaysTesting 
Specificity of Stat-Phosphopeptide Interac- 
tions 
Curves show competition of various unlabeled 
peptides for Stat-receptor peptide complexes 
under reaction conditions identtcal to those 
used for Figure 2. Protein concentration was 
the following: Statl, 160 nM; and Stat& IOOCt 
nM. Intheffgure10096isdeffnedasnocompe 
tition from unlabeled peptides. (A-C) show 
binding reactions using Statl-fluoreacein- 
labeled IFNy receptor phosphopepttde; (D-F) 
used StatWluorescein-fabeled IL4 phos- 
phopeptide. Competitor peptides were the fof- 
lowing: (A) and(F), IFNy receptor phoaphopep 
tide SFGYPDKHVL: (C) and (D), IL-4 receptor 
phosphopeptide AfXGEEGYXPFQDLI; (B), 
desphosphate IFN, receptor peptfde SFGYD 
KHVL; and (E), desphosphate IL4 peptide 
ASBGEEGYKPFQDLI. 
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Figure 4. DNA Binding Properties of Native 
and Recombinant Forms of Stat1 and Stat3 on 
N3 and N4 Recognition Sites 
EMSAs were used toexamine the DNA binding 
properties of recombinant and native forms of 
Stat1 and Stat3 on optimal binding s&s se 
lected from randomized oligonucleotide pools 
(see Experimental Procedures). Binding site 
selection with Stat1 yielded the dyad symmet- 
ric sequence 5”TTCN3GkW(N3 probe, top). 
Binding site selection using Stat3 yielded the 
dyad symmetric sequence 5’-lTCN4GAAS’ 
(N4 probe, bottom). For each protein, one of 
the sekted sites was chosen to serve as a 
probe in the mobility shift assay (see Experi- 
mental Procedures). The left lane of each gel 
utilized nuclear extract prepared from unin- 
duced THp-1 cells, which did not contain DNA 
binding activities capable of speciffc interac- 
tion with either the N3 or N4 probe. Alternating 
lanes utilized nuclear extracts prepared from 
either IL4 or IFfly-induced THpl cells. Anti- 
bodies specific to Stat6 and Stat1 were used 
to resolve the molecular identities of the IL4 
and IFNy-induced DNA binding activities. Re 
combinant actfvated Stat3 and Stat1 proteins 
(see Figure 1) were tested in the rightmost 
lanes of each gel. NS, designates a protein- 
DNA complex mediated by a nonspecifically 
binding activity. 
this recognition motif. Of the sequenced fragments, 8 con- 
tained single base substitutions in one of the two dyad 
half-sites. All 8 of these variants, however, contained a 3 
bp spacing between the dyad half-sites. 
Similar experiments using Stat8 led to the identification 
and sequencing of 42 DNA fragments, all bearing the same 
dyad symmetric half-site as was obsenred for the Stat1 
recognition element (9lTC-3’). In the case of the StatG- 
selected DNA fragments, however, the dyad half-sites in 
38 cases were separated by 4 bp (5’-TTCN4GAA-3’) and 
in only four cases by 3 bp (5’-TTCN3GAA-31. As was the 
case for Stat1 -selected binding sites, a proportion (10) of 
the StatG-selected binding sties contained a single base 
substitution in one of the dyad half-sites. 
DNA sequences selected with Stat1 and Stat8 were 
tested in gel mobility shift assays using recombinant pro- 
teins purified from baculovirus-infected cells as well as 
native Stat1 and Stat8 proteins produced in THpl cells in 
response, respectively, to IFNy and IL-4. The Stat1 recog- 
nition site, designated N3, bound efficiently to both recom- 
binant and native Statl, but was only weakly bound by 
the two preparations of Stat8 protein (Figure 4). Con- 
versely, the Stat8 recognition site, designated N4, bound 
efficiently to both native and recombinant Stat8, yet failed 
to bind Statl. Apparently, although Stat1 and Stat8 bind 
to the same dyad symmetric recognition element, the 
spacing between dyad half-sites significantly influences 
binding avidity. 
To assess and compare DNA-binding specificities of 
Stat1 and Stat8 to the N3 and N4 recognition sites quanti- 
tatively, we performed competition assays in which con- 
stant amounts of protein were incubated with radioactively 
labeled DNA in the presence of varying concentrations of 
unlabeled competitor DNA. Stat1 binding to the N3 site 
was competed by an unlabeled N3 oligonucleotide, yet 
was insensitive to competition by up to three orders of 
magnitude higher concentrationsof an unlabeled N4oligo- 
nucleotide (Figure 5, top). Stat8 binding to the N4 site 
was roughly one order of magnitude more sensitive to 
competition by its cognate N4 site than the Statl-selected 
N3 site (see Figure 4, bottom). Interpreted most simply, 
these data indicate that Stat1 should not, on its own, be 
capable of regulating gene expression via optimal Stat8 
binding sites. Conversely, although optimized for binding 
to N4 sites, Stat8 may be capable of activating gene ex- 
pression via N3 sites. 
The results outlined thus far provide evidence for two 
levels of molecular specificity in the Stat regulatory path- 
way. Stat1 bound directly and selectively to a tyrosine- 
phosphorylated peptide derived from the IFNy receptor 
and selected a symmetric DNA recognition site wherein 
dyad half-sites were separated by 3 bp. Stat8 bound to a 
different phosphopeptide, derived from the IL-4 receptor, 
and selected a DNA recognition site wherein dyad half- 
sites were separated by 4 bp. To map the functional do- 
mains responsible for these varied properties, we pre- 
pared the six chimeric Statl-Stat8 proteins shown in 
Figure 8A. 
Each chimeric protein was expressed in insect cells 
coinfected with a baculovirus recombinant-expressing 
Jak2 (see Experimental Procedures). Purified Jak-acti- 
vated chimeric proteins were first tested for DNA binding 
specificity using the optimal Stat1 (N3) and Stat8 (N4) bind- 
ing sites. The 1/8A, l/8& and 1/8C recombinant% which 
C&nponents of a Stat Recognition Code 
N3 Probe 
Stat 1 
N4 Probe 
Stat 6 
Figure 5. Quantitative Assays of Stat1 and Stat6 Binding to N3 and 
N4 Recognition Sites 
Each binding reaction contained the same concentration of purified 
activated Stat protein (roughly 5 nM) and radioactive probe DNA 
(roughly 0.5 nM). Top two panels utilized Stat1 and radiilabeled N3 
probe; bottom two panels utilized Stat6 and radiolabeled N4 probe. 
Cold competitor DNA was added to binding reactions starting at a 
IO-fold molar excess (second lane) and increasing by half-log incre 
men& up to a 3,OOCMold molar excess (right lane) as indicated above 
each panel. 
contained progressively more extended segments of Stat1 
reciprocally fused to Stat6, all bound selectively to the N4 
recognition site (Figure 6B). Such observations indicate 
that DNA binding specificity maps on the carboxy-terminal 
side of residue 266 of Stat6. The 1160 chimera failed to 
bind to either the N3 or N4 recognition site, despite being 
expressed and purified as a soluble polypeptide. DNA 
binding specificity was abruptly reversed for the 116E and 
116F chimeras, allowing delineation of Stat1 DNA binding 
specificity to a region on the amino-terminal side of residue 
492. Collectively, these results localize the region that de- 
termines Stat DNA binding specificity. 
Each chimeric protein was further tested for interaction 
with receptor-derived tyrosine phosphopeptides. Previous 
studies have shown that the DNA binding activities of Stat 
proteins can be inhibited by phosphopeptides derived 
from their activating receptors (Hou et al., 1994; Lin et al., 
1995). This peptide-specific phosphotyrosinedependent 
inhibition probably results from the ability of receptor phos- 
phopeptides to prevent reassociation of transiently disso- 
ciated Stat dimers (Hou et al., 1994). As shown in Figure 
7, the DNA binding activities of all Statl-Stat6 chimeric 
proteins were inhibited by the IL4Rderived phosphopep- 
tide, and none of the activities were inhibited by the IFNy 
receptor-derived phosphopeptide. These observations 
allow localization of the phosphopeptide-sensitive domain 
of Stat6 to a position on the carboxy-terminal side of resi- 
due 524. 
Discussion 
The results outlined in this study of the human forms of 
Stat1 and Stat6 give evidence of two levels of molecular 
specificity. We propose that initial activation of a Stat pro- 
tein is gated by selective receptor coupling. Stat1 is acti- 
vated by IFNy as a function of its ability to bind to the 
intracellular domain of the IFNr receptor. Stat6 is likewise 
selectively activated by IL-4 due to its ability to couple 
directly to the lL-4R. Similar interpretations have been pro- 
posed in earlier studies (Greenlund et al., 1994; Hou et 
al., 1994), yet the present work provides unequivocal evi- 
dence of direct interaction between Stat proteins and 
phosphopeptides derived from their cognate receptors. 
Similar observations and interpretations have been made 
by Greenlund et al. (1995 [this issue of /mmunity]). Al- 
though we postulate that the Stat-phosphopeptide inter- 
actions characterized herein contribute to selective cyto- 
kine signaling, it remains formally possible that other Stat 
and receptor polypeptide domains also contribute to their 
molecular interaction. Once coupled to the intracellular 
domain of its cognate receptor, we hypothesize that a Stat 
protein is afforded favorable proximity for tyrosine phos- 
phorylation, presumably by a member of the Jak family 
of tyrosine kinases (Darnell et al., 1994). Thus activated, 
Stat proteins are able todimerize, reciprocally exchanging 
tyrosine-phosphorylated tails and thereby loading the mo- 
lecular cleft previously used for receptor docking. 
A second level of molecular selectivity was revealed by 
studies of the DNA binding properties of Stat1 and Stat6. 
Both of these transcription factors recognize dyad sym- 
metric regulatory elements characterized by half-sites 
bearing the trinucleotide sequence 5’-l-X-3’. Surprisingly 
distinct binding specificities were revealed, however, by 
the discovery that Stat1 favors a 3 bp spacing between 
dyad half-sites (5’-lTCN3GAA-3’) and Stat6 a 4 bp spacing 
(5’-lTCN4GAA-3’). By testing synthetic oligonucleotides 
bearing various Stat binding sites, Seidel et al. (1995) have 
arrived at similar conclusions. It is notable that the majority 
of IFNy response elements, termed GAS elements, bear 
the canonical N3 spacing (Kanno et al., 1993; Sims et al., 
1993; Wegenka etal., 1993; Darnell et al., 1994). Likewise, 
IL4 response elements bear the canonical N4 spacing 
(Sideras et al., 1969; Suter et al., 1969; Rothman et al., 
1990; Kotanides and Reich 1993; Delphin and Stavnezer, 
1995). Interestingly, Seidel et al. (1995) recently demon- 
strated that the IL-&induced Stat3containing complex 
preferentially interacts with a DNA element containing the 
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Figure 6. Assessment of DNA Binding Specificities of Chimeric Statl-Stat6 Proteins 
(A) Schematic diagrams of Statl, Stats, and chimeric Statl-Stat6 proteins. Recombination points for chimeric proteins were designated by the 
most carboxy-terminal residue of Stat1 and most amino-terminal residue of Stat6, wherein MA = 117l94; II60 = 236l2g2; 1% 1 3091288; 
1/6D - 397/35X3; 1/6E = 492/446; and 1/6F = 5631524. Bottom diagram shows locations of pclypeptide domains conserved among all stat proteins 
(black) positioned below an assignment of their presumed structural or functional properly. 
(B) Molecular characterization of chimeric Statl-Stat6 proteins. Top panel shows Coomassie stain of SDS electrophoresis gel used to size chimeric 
proteins. Second panel shows Western blot of same proteins as detected with antibodies specific to Stat6. Bottom panels show EMSAs using 
optimal Stat6 (N4 probe) and Stat1 (N3 probe) binding sites. Rightmost lanes show gel shift assays using intact recombinant Stat6 and Stat1 
proteins. 
same two half-sites spaced by 2 bp (5lTCN2GAA-3’). 
Although additional studies will be required to test more 
thoroughly these binding selectivity rules, we believe that 
they provide a simple conceptual framework for under- 
standing how different cytokines selectively reprogram 
gene expression. 
The two molecular specificities of Stat proteins uncov- 
ered in this study, receptor coupling and DNA binding, 
map to distinct domains. DNA binding specificity was local- 
ized to a region of 180 aa on the amino-terminal side of 
the putative SH3 domain (Figure 8). Stat proteins bear two 
distinct pockets of primary amino acid sequence similarity 
inthis region, designated box A and box 6 (Figure 8). The 
recombination points at which DNA binding activity was 
reversed closely bracketed these conserved regions. The 
1/8C recombination point was positioned at the amino acid 
residue immediately adjacent to the first conserved posi- 
tion (Leu) of box A. The 1/8E recombination point was 
positioned 17 residues downstream from the terminal posi- 
tion (Asn) of box 6. Given that the 118C and 1/8E recombi- 
nation steps clearly and abruptly reversed DNA binding 
specificity (Figure 8), we hypothesize that the box A and 
box B regions may constitute a part of the molecular sur- 
face utilized by Stat proteins to contact DNA. 
It is notable that a chimeric Statl-Stat8 protein recom- 
bined between these conserved motifs, the 1/8D recombi- 
nant, failed to bind either the N3 or N4 recognition site 
(Figure 8). Although care was taken to preserve molecular 
alignment, and the 118D chimera was expressed in a solu- 
ble form, it exhibited no detectable DNA binding activity. 
We offer three possible interpretations regarding this ob- 
servation. First, box A of one Stat protein may be incapable 
of interacting with box 6 of another Stat in a manner per- 
missive for molecular function. Second, the polypeptide 
region between these conserved regions, although not 
conserved among Stat proteins, may play a functional role 
in DNA binding. The methods used to construct the chime- 
ric Stat proteins described herein resulted in the substitu- 
tion of two amino acid residues which, in the case of the 
1180 chimera, might impede DNA binding activity. Finally, 
the 118C chimera might retain a DNA binding activity dis- 
tinct from either of the parental proteins. Further studies 
will be required to resolve these ambiguities. 
Analysis of chimeric Stat proteins gave evidence that 
receptor coupling is specified by a region located on the 
carboxy-terminal side of the SH3 domain, presumably cor- 
responding to the SH2 domain. Such obsewations are 
consistent with the results of previous biochemical 
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Figure 7. Inhibition of DNA Binding Activities of Statl, Stats, and Chi- 
merit StatIStat Proteins by Tyrosine Phosphopeptides Derived 
from the IFNy and IL-4 Receptors 
Each DNA binding reaction contained the same concentration of re- 
combinant Stat protein (5 nM). The Stat1 binding reaction was carried 
out with radiolabeled N3 probe at concentration of 0.5 nM. The Stat6 
and chimeric Stat1 -Stat6 binding reactions were carried out with radio- 
labeled N4 probe at a concentration of 0.5 nM. Left lane of each gel 
shift was conducted in the absence of receptor peptide. Middle and 
right lanes were carried out with Stat proteins that had been preincu- 
bated with tyrosine phosphopeptides derived, respectively, from the 
IL-4R and IFNy receptor (see Experimental Procedures). 
(Greenlund et al., 1994; Hou et al., 1994) and molecular 
biological (Heim et al., 1995; Stahl et al., 1995) studies of 
Stat proteins. As predicted previously (Hou et al., 1994) 
this receptor coupling domain probably corresponds to the 
dimerization interface utilized by activated Stat proteins. 
Whereas selective Stat activation provides a rational basis 
for understanding how cytokines are able to reprogram 
gene expression differentially, we point out that other sig- 
naling pathways may also be selectively utilized in re- 
sponse to different cytokines. For example, evidence has 
been presented showing that IL-2, 11-3, and granulocyte/ 
macrophage-colony-stimulating factor activate the ras 
p21 protein, but IL4 does not (Satoh et al., 1991). 
In closing, we note a parallel between the molecular 
features governing cytokine-mediated gene regulation 
and that regulated by the more extensively studied organic 
hormones such as estrogens, glucocorticoids, and reti- 
noids. The latter class of hormones penetrate cells and 
interact directly with nuclear receptors. Two levels of mo- 
lecular selectivity define the battery of genes induced by 
aspecificchemical hormone. First, agiven hormone binds 
avidly and selectively to its cognate intracellular receptor 
via a definable hormone binding domain. Second, the acti- 
vated nuclear hormone receptor binds to a restricted bat- 
tery of genes, leading either to the activation or repression 
of transcription. DNA binding selectivity of nuclear recep 
tors has been determined to vary according to the spacing 
of discrete binding modules that can be organized in either 
a dyad symmetric or directly repeated organization. Evans 
and coworkers have proposed and documented a recogni- 
tion code, designated the 3, 4,5 rule, that illuminates the 
distinct molecular specificities of the retinoid, vitamin D, 
and thyroid hormone receptors (Umesono et al., 1991). 
Polypeptide hormones, such as the cytokines studied 
herein, do not enter cells and directly interact with the 
transcription factors that they ultimately regulate. The Stat 
proteins controlled by IFNy and IL4 do, however, bear 
molecular features reminiscent of nuclear hormone recep- 
tors. Cytokine specificity, we propose, is dictated by the 
selective ability of Stat proteins to couple to their appro- 
priate receptor. We compare this receptor coupling func- 
tion of Stat proteins to the hormone recognition function 
of nuclear receptors. We likewise postulate that the DNA 
recognition codes of cytokine and organic chemical hor- 
mones are comparable, in both cases being dictated by 
the spatial organization modular recognition motifs. Thus, 
the principles that have emerged from studies of these 
very different biological response modifiers appear unex- 
pectedly concordant. 
Expertmental Procedures 
Expmsslon and Purlfkatkn of Recombinant Stat Protelna 
cDNA fragments encoding Stat1 (Schindler et al., 1992) and Stat6 
(Hou et al., 1994) were cloned between the SamHI and Not1 sites of 
the baculovirus expression vector pVLl393 (Pharmingen). Both pro- 
teins were altered at their carboxyf termini to contain nine His residues 
as well as a pentapeptide substrate (RRASV) for protein kinase A. The 
Jak2 cDNA (Silvennoinen et al., 1993) was cloned into the Xbal site 
of the baculovirus expression vector pVL1392 (Pharmingen). The six 
chimeric Statl-Stat6 proteins(MA-l/t)F)were generated using PCR 
such that recombination pointswerejoined at a uniqueXba1 restriction 
site. The junctions for each of the six proteins were the foflowing: 116A, 
ERKILOVATFRQ; MB, NDELIEMKRQDD; 1/6C, FSLRsr/LVTSCF; 
1/6D, ESTNsr/GNCCSA; ME, TPPCsR/WEKMCE; l/BE, WIESIU 
DLTKRC. Capital letters refer to the native amino acid sequences of 
Stat1 on the left of the shill and Stat6 sequences on the right side of 
the shill. Small letters refer to amino acid substitutions generated as 
immunity 
696 
box A box B 
Stat 1 312 
Stat 2 311 
Stat 3 316 
Stat 4 312 
Stat 5 327 
Stat 6 268 
-------(Ill)-- ----- 
------- (116) ------- 
--------(119)------- 
-------(IId)------- 
-------(115)------- 
-------(118)------- 
-475 
-473 
-481 
-472 
-486 
-430 
cOnSenSLlS L--s-p--QpcMp--------( )--------L-I-L-T-SLPVWISN--Q--NAWASILW-N-(17) 
1/6C 1/6D 1/6E 
Figure 6. Conserved Regions of the Putative Stat DNA Binding Domain 
The figure shows amino acid sequences of six Stat proteins in the putative DNA binding domain. Numbers on the left of each amino acid sequence 
refer to the position of the conserved Leu (L) within the intact sequence of each Stat protein. Numbers indicated in parentheses indicate the 
distance in amino acid residues separating the conserved Pro (P) from the conserved Leu (L) for each Stat protein. Numbers on the right of each 
amino acid sequence refer to the position of the consewed Asn (N) within the intact sequence of each Stat protein. Amino acid residues present 
in four or more members of the Stat family are shaded and specified below (consensus). Dashes indicate amino acids; dots refer to missing amino 
acids. As shown at the bottom, the 1/6C chimera was recombined on the immediate amino-terminal side of the first Leu (L) of the leftward conserved 
segment (box A). The 116D chimera was recombined at a position between the two conserved segments, and the 116E chimera was recombined 
17 residues to the right of the last Asn (N) of the rightward conserved segment (box B). 
a function of introduction of the Xbal restriction site. The integrity of izationdepsndent detector sensitivity was corrected in all polarization 
each construct was confirmed by automated DNA sequencing. assays. 
Recombinant proteins were expressed in High Fiveceiis(invitrogen) 
and harvested 72 hr post infection. The ceils (4 x 103 were iysed in 
10 ml iysis buffer (20 mM HEPES. NaOH [pH 7.91, 100 mM NaCI, 
0.1% NP40, 15% glycerol, 2 mM &mercaptcethanol, 1 mM PMSF) 
supplemented with 15 mM imidezol. After centrifugation (10 min at 
10,000 rpm) the supernatant was added to 0.5 ml of packed NP+-NTA 
agarose (Quigen) and incubated at 4OC for 1 hr with constant rotation. 
The slurry was transferred to a disposable plastic column, washed 
with 20 voi of iysis buffer containing 15 mM imidazol, followed by 20 
vol of lysis buffer containing 30 mM imidazol. Stat proteins were step 
eluted with iysis buffer supplemented with 50, 60, 70, 60, 100, and 
250 mM imidazole. 
The assay buffer used for Statl-receptor peptlle binding consisted 
of 150 mM NaCi, 10 mM HEPES (pH 7.4), 3 mM EDTA, 0.1% NP-40, 
and 2 mM 8-mercaptoethanoi. Assay buffer used for StaM-receptor 
peptide binding consisted of 10 mM NaCi, 40 mM NaF, 10 mM HEPES 
(pH 7.9) 1 mM EDTA, 1 mM NaVO,, 0.1% NP40 and 2 mM &mercap 
Methanol. 
PrePamtion of THpl Nucfear Extrscte 
THpI cells were grown as described by Hou et al. (1994) and stimu- 
lated with either IL4 (5 @ml) or IFNy (I5 @ml) for 15 min at 37OC. 
Nuclear extracts were prepared from uninduced, IL-t-induoed, and 
IFNy-induced THpl ceils according to @born et al. (1969). 
Tyrosine-phosphorylated Stat proteins were generated by coinfect- 
ing High Fiveceils with a Jak2(Harpur etal., 1992) baculovirusexpres- 
sion vector. Nuclear proteins were prepared as described by Osborn 
et al. (1969) except that the phosphatase inhibitors N&VO,, NaF, and 
6glyceroiphosphate (1 mM) were added to all buffers. The nuclear 
extracts were adjusted to 100 mM NaCI, 15 mM imidazole, and 2 mM 
6-mercaptoethanoi and proteins were purified on NP+-NTA agarose 
as described above. Latent and activated Stat proteins were separated 
by DNA affinity chromatography as described by Hou et al. (1994) 
except that the N3 and N4 binding sites (see below) were used to 
purify Stat1 and Stat6, respectively. 
DNA Blndlng Assays 
PeptIde Synthesie and fluorescence Polarization Assays 
Tyrosine phosphorylated forms of the IFrJr (GYPDKPHVL)and IL4R 
(GYPKPFQDL) peptides were synthesized as described previously 
(Hou et al., 1994). 5/6carboxyfluorescein succinimidyi ester was cou- 
pled to the N-terminal amino group and the fluorescent peptides were 
purified by reverse-phase high pressure liquid chromatography. When 
purified by thin-layer chromatography, both the 5 and 6 isomers of 
the fluorescein peptides gave the same results in Stat binding assays. 
Therefore, the mixture was used in all subsequent binding experi- 
ments. 
EMSAs were used to visualize protein-DNA complexes. The N3 probe 
was prepared by annealing the following two oligonucieotides: (i) 
S%ATCTGlTAACTTCCCGGAGATGS’; (ii) 5%ATCCATCTTCCG- 
GGAAGlTAACA-3’. The N4 probe was prepared by annealing the 
following two oiigonucieotides: (i) 5’GATCTGTAATTCGTGTGA 
TATG-3’; (ii) 5’GATCCATAATTCACACGA3’. Following an- 
nealing, the oligonucieotides were radlolabeied with [a-SPMATP and 
[a-52PJdGTP using a fill-in reaction (Sambrook et al., 1969). Competi- 
tive DNA binding studieswere carried out by including unlabeled oiigo 
nucleotides. For antibody inhibition studies, Stat proteins were lncu- 
bated with antiserum for 15 min at 24OC before addition of the 
radioactive DNA probe. Peptide inhibition experiments were per- 
formed by incubating Stat proteins for 30 min at 24OC with a 300 uM 
wncentration of tyrosine-phosphorylated peptides derived from either 
the lL4R (NH&PPGEAGYPKAFSSLL-CGGH) or the IFNy receptor 
(NHrTSFGYPDKPHCWH) before addiion of the radiile DNA 
probe. Gel eiectrophcresis wnditions were performed as described 
by Hou et al. (1994). 
DNA Binding Site Sebctlon 
Fluorescence polarization was measured in an FPM-1 analyzer 
(Jolly Consulting and Research). The wavelength of excitation was 
selected at 465 nm (bandwidth 22 nm) and that of emission at 530 
nm (bandwidth 30 nm) using interference filters (Omega Optical). Ail 
measurements were taken at 24OC. The instrument was checked with 
a low polarization standard (free fluorescein) and with a high polariza- 
tion standard (fluorescein immobilized onto immunogiobulin). Polar- 
Optimal Stat1 and Stat6 binding sites were selected from the following 
pool of oiigonucieotides: 5’- GTCTGTCTGAGGTGagatctATNldCaag 
CttGTCTAGCGACGTCGCG- 3’. Residues shown in lower case repre 
sent Sac1 and Hindlil sites used for subsequent cloning. N14 cone 
sponds to residues that were randomized for all four bases. Binding 
selection was carried out as described by Schindler et al. (1992) wlth 
the following modifications. Only three rounds of selection were per- 
&rmonents of a Stat Recognition Code 
formed. Double-stranded oligonucleotide probes for the second and 
third roundsweregenerated by PCR using thefollowing reaction condi- 
tions: 1 min at 94%, 1 min at 55%, and 30 s at 72% for 10 cycles. 
Reactions were carried out in 50 ul vol according to the specifications 
of the manufacturer (Perkin-Elmer), except that dCTP was replaced 
by 10 pL (3,000 CilmMol) of [a-92P)CTP. After the third mobility shift 
assay, the bound DNA was eluted, amplified as described above but 
in the absence of radioactive dCTP and for 20 reaction cycles. The 
resulting oligonucleotides were cloned into the Sac1 and Hindlll sites 
of pSluescript SK(+) and subjected to automated DNA sequencing. 
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